Literature DB >> 19339511

FXYD1 phosphorylation in vitro and in adult rat cardiac myocytes: threonine 69 is a novel substrate for protein kinase C.

William Fuller1, Jacqueline Howie, Linda M McLatchie, Roberta J Weber, C James Hastie, Kerry Burness, Davor Pavlovic, Michael J Shattock.   

Abstract

FXYD1 (phospholemman), the primary sarcolemmal kinase substrate in the heart, is a regulator of the cardiac sodium pump. We investigated phosphorylation of FXYD1 peptides by purified kinases using HPLC, mass spectrometry, and Edman sequencing, and FXYD1 phosphorylation in cultured adult rat ventricular myocytes treated with PKA and PKC agonists by phosphospecific immunoblotting. PKA phosphorylates serines 63 and 68 (S63 and S68) and PKC phosphorylates S63, S68, and a new site, threonine 69 (T69). In unstimulated myocytes, FXYD1 is approximately 30% phosphorylated at S63 and S68, but barely phosphorylated at T69. S63 and S68 are rapidly dephosphorylated following acute inhibition of PKC in unstimulated cells. Receptor-mediated PKC activation causes sustained phosphorylation of S63 and S68, but transient phosphorylation of T69. To characterize the effect of T69 phosphorylation on sodium pump function, we measured pump currents using whole cell voltage clamping of cultured adult rat ventricular myocytes with 50 mM sodium in the patch pipette. Activation of PKA or PKC increased pump currents (from 2.1 +/- 0.2 pA/pF in unstimulated cells to 2.9 +/- 0.1 pA/pF for PKA and 3.4 +/- 0.2 pA/pF for PKC). Following kinase activation, phosphorylated FXYD1 was coimmunoprecipitated with sodium pump alpha(1)-subunit. We conclude that T69 is a previously undescribed phosphorylation site in FXYD1. Acute T69 phosphorylation elicits stimulation of the sodium pump additional to that induced by S63 and S68 phosphorylation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19339511      PMCID: PMC2692419          DOI: 10.1152/ajpcell.00523.2008

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  33 in total

1.  Phospholemman phosphorylation alters its fluorescence resonance energy transfer with the Na/K-ATPase pump.

Authors:  Julie Bossuyt; Sanda Despa; Jody L Martin; Donald M Bers
Journal:  J Biol Chem       Date:  2006-08-30       Impact factor: 5.157

2.  Serine 68 phospholemman phosphorylation during forskolin-induced swine carotid artery relaxation.

Authors:  Christopher M Rembold; Marcia L Ripley; Melissa K Meeks; Lisa M Geddis; Howard C Kutchai; Francesca M Marassi; Joseph Y Cheung; J Randall Moorman
Journal:  J Vasc Res       Date:  2005-09-06       Impact factor: 1.934

3.  Cytoplasmic targeting signals mediate delivery of phospholemman to the plasma membrane.

Authors:  Kristan L Lansbery; Lauren C Burcea; Margaretta L Mendenhall; Robert W Mercer
Journal:  Am J Physiol Cell Physiol       Date:  2005-12-21       Impact factor: 4.249

4.  Phospholemman-phosphorylation mediates the beta-adrenergic effects on Na/K pump function in cardiac myocytes.

Authors:  Sanda Despa; Julie Bossuyt; Fei Han; Kenneth S Ginsburg; Li-Guo Jia; Howard Kutchai; Amy L Tucker; Donald M Bers
Journal:  Circ Res       Date:  2005-07-07       Impact factor: 17.367

5.  Serine 68 of phospholemman is critical in modulation of contractility, [Ca2+]i transients, and Na+/Ca2+ exchange in adult rat cardiac myocytes.

Authors:  Jianliang Song; Xue-Qian Zhang; Belinda A Ahlers; Lois L Carl; JuFang Wang; Lawrence I Rothblum; Richard C Stahl; J Paul Mounsey; Amy L Tucker; J Randall Moorman; Joseph Y Cheung
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-01-14       Impact factor: 4.733

6.  Identification of a cytoskeleton-bound form of phospholemman with unique C-terminal immunoreactivity.

Authors:  C E Kelly; M L Ram; S A Francis; T D Houle; S E Cala
Journal:  J Membr Biol       Date:  2004-12       Impact factor: 1.843

7.  Phospholemman phosphorylation mediates the protein kinase C-dependent effects on Na+/K+ pump function in cardiac myocytes.

Authors:  Fei Han; Julie Bossuyt; Sanda Despa; Amy L Tucker; Donald M Bers
Journal:  Circ Res       Date:  2006-11-09       Impact factor: 17.367

8.  Expression and phosphorylation of the na-pump regulatory subunit phospholemman in heart failure.

Authors:  Julie Bossuyt; Xun Ai; J Randall Moorman; Steven M Pogwizd; Donald M Bers
Journal:  Circ Res       Date:  2005-08-11       Impact factor: 17.367

9.  Phospholemman-mediated activation of Na/K-ATPase limits [Na]i and inotropic state during beta-adrenergic stimulation in mouse ventricular myocytes.

Authors:  Sanda Despa; Amy L Tucker; Donald M Bers
Journal:  Circulation       Date:  2008-03-24       Impact factor: 29.690

10.  The intracellular region of FXYD1 is sufficient to regulate cardiac Na/K ATPase.

Authors:  Davor Pavlović; William Fuller; Michael J Shattock
Journal:  FASEB J       Date:  2007-02-05       Impact factor: 5.191

View more
  39 in total

1.  Intracellular trafficking of FXYD1 (phospholemman) and FXYD7 proteins in Xenopus oocytes and mammalian cells.

Authors:  Shiri Moshitzky; Carol Asher; Haim Garty
Journal:  J Biol Chem       Date:  2012-04-25       Impact factor: 5.157

2.  Post-transcriptional control of Na,K-ATPase activity and cell growth by a splice variant of FXYD2 protein with modified mRNA.

Authors:  Kathleen J Sweadner; Jennifer L Pascoa; Cynthia A Salazar; Elena Arystarkhova
Journal:  J Biol Chem       Date:  2011-04-01       Impact factor: 5.157

3.  Role of phospholemman phosphorylation sites in mediating kinase-dependent regulation of the Na+-K+-ATPase.

Authors:  Fei Han; Julie Bossuyt; Jody L Martin; Sanda Despa; Donald M Bers
Journal:  Am J Physiol Cell Physiol       Date:  2010-09-22       Impact factor: 4.249

4.  Molecular Mechanisms and Kinetic Effects of FXYD1 and Phosphomimetic Mutants on Purified Human Na,K-ATPase.

Authors:  Neeraj Kumar Mishra; Michael Habeck; Corinna Kirchner; Haim Haviv; Yoav Peleg; Miriam Eisenstein; Hans Juergen Apell; Steven J D Karlish
Journal:  J Biol Chem       Date:  2015-10-01       Impact factor: 5.157

5.  Phosphomimetic mutations enhance oligomerization of phospholemman and modulate its interaction with the Na/K-ATPase.

Authors:  Qiujing Song; Sandeep Pallikkuth; Julie Bossuyt; Donald M Bers; Seth L Robia
Journal:  J Biol Chem       Date:  2011-01-10       Impact factor: 5.157

6.  Regulation of L-type calcium channel by phospholemman in cardiac myocytes.

Authors:  Xue-Qian Zhang; JuFang Wang; Jianliang Song; Joseph Rabinowitz; Xiongwen Chen; Steven R Houser; Blaise Z Peterson; Amy L Tucker; Arthur M Feldman; Joseph Y Cheung
Journal:  J Mol Cell Cardiol       Date:  2015-04-25       Impact factor: 5.000

7.  Phospholemman and beta-adrenergic stimulation in the heart.

Authors:  JuFang Wang; Erhe Gao; Jianliang Song; Xue-Qian Zhang; Jifen Li; Walter J Koch; Amy L Tucker; Kenneth D Philipson; Tung O Chan; Arthur M Feldman; Joseph Y Cheung
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-12-11       Impact factor: 4.733

8.  Phospholemman Ser69 phosphorylation contributes to sildenafil-induced cardioprotection against reperfusion injury.

Authors:  Melanie Madhani; Andrew R Hall; Friederike Cuello; Rebecca L Charles; Joseph R Burgoyne; William Fuller; Adrian J Hobbs; Michael J Shattock; Philip Eaton
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-06-11       Impact factor: 4.733

9.  Effects of PKA phosphorylation on the conformation of the Na,K-ATPase regulatory protein FXYD1.

Authors:  Peter Teriete; Khang Thai; Jungyuen Choi; Francesca M Marassi
Journal:  Biochim Biophys Acta       Date:  2009-09-15

10.  Fibre type-specific change in FXYD1 phosphorylation during acute intense exercise in humans.

Authors:  Martin Thomassen; Robyn M Murphy; Jens Bangsbo
Journal:  J Physiol       Date:  2013-01-28       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.